Attenuation of pharmacologically-induced attentional impairment by methylphenidate in rats

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 1, 2009, Pages 141-146

  Rezvani, Amir H ^a   Kholdebarin, Ehsan ^a   Cauley, Marty C ^a   Dawson, Elizabeth ^a   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cognition; Dizocilpine; Mecamylamine; MK 801; Ritalin ; Scopolamine; Sustained attention; Visual signal detection task

Indexed keywords

DIZOCILPINE; MECAMYLAMINE; METHYLPHENIDATE; SCOPOLAMINE;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; ATTENUATION; DRUG MECHANISM; FEMALE; INJECTION; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; TRAINING; VALIDATION STUDY;

ANIMALS; ATTENTION; CENTRAL NERVOUS SYSTEM STIMULANTS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; MECAMYLAMINE; METHYLPHENIDATE; MUSCARINIC ANTAGONISTS; NICOTINIC ANTAGONISTS; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SCOPOLAMINE; SIGNAL DETECTION, PSYCHOLOGICAL; VISUAL PERCEPTION;

ANIMALIA; RATTUS;

EID: 58549119736     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.11.005     Document Type: Article

References (33)

1. Arnsten A.F.T. Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex. In: Solanto M.V., Arnsten A.F.T., and Castellanos F.X. (Eds). Stimulant drugs and ADHD: basic and clinical neuroscience (2001), Oxford University Press, New York 185-208
2. Aspide R., Fresiello A., de Filippis G., Gironi Carnevale U.A., and Sadile A.G. Non-selective attention in a rat model of hyperactivity and attention deficit: subchronic methylphenidate and nitric oxide synthesis inhibitor treatment. Neurosci Biobehav Rev 24 (2000) 59-71
3. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60 (2006) 1111-1120
4. Bizarro L., Patel S., Murtagh C., and Stolerman I.P. Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate. Behav Pharmacol 15 (2004) 195-206
5. Bushnell P.J. Behavioral approaches to the assessment of attention in animals. Psychopharmacology 138 (1998) 231-259
6. Bushnell P.J., Oshiro W.M., and Padnos B.K. Detection of visual signals by rats: effects of chlordiazepoxide and cholinergic and adrenergic drugs on sustained attention. Psychopharmacology 134 (1997) 230-241
7. Castellano C., Cestari V., and Ciamei A. NMDA receptors and learning and memory processes. Curr Drug Targets 2 (2001) 273-283
8. Ellis J.R., Ellis K.A., Bartholomeusz C.F., Harrison B.J., Wesnes K.A., Erskine F.F., et al. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int J Neuropharmacol 9 (2006) 175-189
9. Evenden J., and Ko T. The psychopharmacology of impulsive behavior in rats VIII: effects of amphetamine, methylphenidate, and other drugs on responding maintained by a fixed consecutive number avoidance schedule. Psychopharmacology 180 (2005) 294-305
10. Greenhill L.L., Pliszka S., Dulcan M.K., Bernet W., Arnold V., Beitchman J., et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psych 41 suppl 2 (2002) 26s-49s
11. Grottick A.J., and Higgins G.A. Effects of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res 117 (2000) 197-208
12. Mcgaughy J., Decker M.W., and Sarter M. Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats. Psychopharmacology 144 (1999) 175-182
13. Mcmillen B.A. CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol Sci 4 (1983) 429-432
14. Mirjana C., Baviera M., Invernizzi R.W., and Balducci C. The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacology 29 (2004) 1637-1647
15. Mirza N.R., and Stolerman I.P. Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology (Berlin) 138 (1998) 266-274
16. Mirza N.R., and Bright J.L. Nicotine-induced enhancements in the five-choice serial reaction time task in rats are strain-dependent. Psychopharmacology (Berlin) 154 (2001) 8-12
17. Mishima K., Fujii M., Aoo N., Yoshikawa T., Fukue Y., Honda Y., et al. The pharmacological characterization of attentional processes using a two-lever choice reaction time task in rats. Biol Pharm Bull 25 (2002) 1570-1576
18. Paine T.A., Tomasiewicz H.C., Zhang K., and Carlezon Jr. W.A. Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats. Biol Psychiatry 62 (2007) 687-693
19. Puumala T., Ruotsalainen S., Jäkälä P., Koivisto E., Riekkinen Jr. P., and Sirviö J. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol Learn Mem 66 (1996) 198-211
20. Rezvani A.H., and Levin E.D. Nicotine-glutamate interactions and attentional performance on an operant visual signal detection task in female rats. Eur J Pharmacol 465 (2003) 83-90
21. Rezvani A.H., and Levin E.D. Nicotine-alcohol interactions and attentional performance on an operant visual signal detection task in female rats. Pharmacol Biochem Behav 76 (2003) 75-83
22. Rezvani A.H., Bushnell P.J., Burkholder J.M., Glasgow H.B., and Levin E.D. Specificity of cognitive impairment from Pfiesteria piscicida exposure in rats: attention and visual function vs. behavioral plasticity. Neurotoxicol Teratol 23 (2001) 609-616
23. Rezvani A.H., Bushnell P.J., and Levin E.D. Nicotine and mecamylamine effects on choice accuracy in an operant signal detection task. Psychopharmacology 164 (2002) 369-375
24. Rezvani A.H., Caldwell D.P., and Levin E.D. Nicotine-antipsychotic drug interactions and attentional performance. Eur J Pharmacol 486 (2004) 175-182
25. Rezvani A.H., Caldwell D.P., and Levin E.D. Nicotine-serotonergic drug interactions and attentional performance in rats. Psychopharmacology 179 (2005) 521-528
26. Rezvani A.H., Caldwell D.P., and Levin E.D. Chronic nicotine interactions with clozapine and risperidone and attentional function in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 30 (2006) 190-197
27. Schiffer W.K., Volkow N.D., Fowler J.S., Alexoff D.L., Logan J., and Dewey S.L. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse 59 (2006) 243-251
28. Shannon H.E., and Eberle E.L. Effects of biasing the location of stimulus presentation, and the muscarinic cholinergic receptor antagonist scopolamine, on performance of a 5-choice serial reaction time attention task in rats. Behav Pharmacol 17 (2006) 71-85
29. Shih T.M., Khachaturian Z.S., Barry III H., and Hanin I. Cholinergic mediation of the inhibitory effects of methylphenidate on neuronal activity in the reticular formation. Neuropharmacology 15 (1976) 55-60
30. Spinelli S., Ballard T., Feldon J., Higgins G.A., and Pryce C.R. Enhancing effects of nicotine and impairing effects of scopolamine on distinct aspects of performance in computerized attention and working memory tasks in marmoset monkeys. Neuropharmacology 51 (2006) 238-250
31. Volkow N.D., Wang G.H., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatr 155 (1998) 1325-1331
32. Volkow N.D., Fowler J.S., Wang G.J., Ding Y.S., and Gatley S.J. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur Neuropsychopharmacol 12 (2002) 557-566
33. Warburton D.M., and Brow K. Attenuation of stimulus sensitivity induced by scopolamine. Nature (London) 230 (1971) 126-127